Recognised as one of the leading Travoprost API Manufacturers in India, we operate state-of-the-art facilities equipped with advanced production and testing capabilities. Our expertise in prostaglandin synthesis, coupled with a robust quality assurance framework, ensures consistent and reliable API production. Being among the top Travoprost API Manufacturers in Gujarat and Travoprost API Manufacturers in Vadodara, we prioritise precision manufacturing processes, adherence to cGMP guidelines, and timely deliveries to meet the diverse needs of our domestic and international clients.
Beyond manufacturing, Century Pharma is also a reputed Travoprost API Trader in India, offering flexible supply options to meet varying client demands, from small-scale R&D projects to large-volume commercial requirements. As a reliable Travoprost API Trader in Gujarat and Travoprost API Trader in Vadodara, we ensure seamless procurement support, comprehensive documentation, and global regulatory compliance. Our commitment to transparent communication and dependable delivery timelines has earned us long-standing relationships with pharmaceutical companies worldwide.
Partnering with Century Pharma Ltd. means working with a team dedicated to innovation, quality, and customer satisfaction. Whether you are looking for bulk API supply or customised solutions for formulation development, our Travoprost API offering ensures superior performance and reliability. With decades of experience and a proven track record, we remain the preferred partner for pharmaceutical companies seeking high-quality ophthalmic APIs and tailored manufacturing services in India.
Century Pharma has established a robust global presence, delivering high-quality Active Pharmaceutical Ingredients (APIs) and services across key international markets. With strong footprints in Egypt, Vietnam, Mexico, Russia, Korea, and several MENA/GCC countries (Algeria, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, the United Arab Emirates, and Yemen.), Century Pharma supports pharmaceutical advancements worldwide. Our expertise spans API manufacturing for human and animal health, enzyme production, biotechnology, and API research.
Additionally, Century Pharma excels in Contract API Manufacturing, Contract API Research, Method API Development, and Stability Studies, catering to regulatory and market-specific needs. As a trusted API manufacturer in India, Century Pharma continues to expand its global reach, fostering long-term collaborations and ensuring quality healthcare solutions across continents.
Century Pharma Ltd. is a Travoprost API manufacturer based in Vadodara, Gujarat, India. We support pharmaceutical companies with bulk API sourcing and commercial enquiries. Contact our team to discuss required quantities, product specifications, and delivery needs.
Pharmaceutical buyers can enquire about the applicable Certificate of Analysis (COA) and product specifications. These documents help buyers assess API identity, purity, and batch quality. Contact Century Pharma to confirm documentation availability.
The minimum order quantity depends on product availability and commercial requirements. Buyers can share their expected purchase quantity with Century Pharma to confirm MOQ, pricing, and delivery schedules.
Century Pharma serves international pharmaceutical markets. Buyers can enquire about Travoprost API availability, export documentation, and shipping arrangements for their destination country. Supply is subject to applicable regulatory requirements.
To request a quotation, share your required quantity, product grade, technical specifications, destination country, and expected delivery schedule. Century Pharma can review your requirements and provide available commercial details.
Buyers should review assay, identification, related substances, residual solvents, and applicable pharmacopoeial specifications. They should also check stereochemical identity, degradation impurities, and stability data. These parameters help pharmaceutical manufacturers assess API quality and formulation suitability.
Manufacturers should evaluate API purity, solubility, stability, degradation products, and compatibility with formulation ingredients. They should also review relevant microbial quality and endotoxin requirements. Finished ophthalmic products must meet applicable sterility and quality standards.
Not necessarily. Travoprost API intended for ophthalmic formulations is not automatically sterile. Buyers should confirm its sterility status, microbial specifications, and available quality documentation. They should also assess whether it suits their intended manufacturing and sterilisation processes.
Travoprost requires appropriate stability controls during storage and transport. Buyers should review temperature requirements, degradation impurities, packaging, and any relevant light-protection measures. Product-specific stability data should guide handling and storage decisions.
Travoprost and Latanoprost are different prostaglandin F2α analogue APIs used in approved ophthalmic medicines to reduce elevated intraocular pressure. They differ in chemical structure and physicochemical properties. Pharmaceutical manufacturers should select the API specified in their approved formulation and regulatory documents.
International buyers should request applicable product specifications, a batch COA, GMP evidence, stability information, and available regulatory support documents. They should also confirm import requirements and product-specific compliance for their destination market.